Specialized HIV clinics: a new strategy to beat the virus?

NCT ID NCT07747987

Completed Disease control Sponsor: Centre for Infectious Disease Research in Zambia Source: ClinicalTrials.gov ↗

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This study in Zambia evaluates whether dedicated 'viremic clinics'—where people with HIV who have high viral loads receive extra support from a team of healthcare providers—can improve viral suppression. The trial includes 548 participants aged 15 and older who have been on first-line antiretroviral therapy for at least 6 months. Researchers will measure viral suppression after 3 months and identify barriers and facilitators to success.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: additional support
What this could lead to: If effective, this approach could improve viral suppression rates and inform better HIV care models in resource-limited settings.
What could go wrong: This is a programmatic evaluation, not a randomized controlled trial, so results may be influenced by other factors and may not be generalizable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV (HUMAN IMMUNODEFICIENCY VIRUS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV (HUMAN IMMUNODEFICIENCY VIRUS)

Contacts and locations

Locations

CIDRZ

Lusaka, 10101, Zambia

More trials for these conditions

Other studies related to the condition(s) this trial covers.